Paper36792575
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
Ivanochko D and 24 others. Immunity, 2023. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230. Papers, record 36792575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36792575
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria, Falciparum | Major topic |
| Malaria Vaccines | Major topic |
| Humans | |
| Animals | |
| Plasmodium falciparum | |
| Epitopes | |
| Protozoan Proteins | |
| Antigens, Protozoan | |
| Antibodies, Monoclonal | |
| Antibodies, Protozoan |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K24 AI144048 | NIAID NIH HHS | United States | K24AI144048 | PubMed | NIH RePORTER |
| S10 OD012289 | NIH HHS | United States | S10OD012289 | PubMed and NIH | NIH RePORTER |
| K24 AI113002 | NIAID NIH HHS | United States | K24AI113002 | PubMed and NIH | NIH RePORTER |
| U19 AI089674 | NIAID NIH HHS | United States | U19AI089674 | PubMed and NIH | NIH RePORTER |
| R01 AI093615 | NIAID NIH HHS | United States | R01AI093615 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 36792569 | X marks the shot against malaria. | https://conductscience.org/library/papers/36792569 |
Source PubMed
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31551421 | Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25. | Nat Commun | 2019 | https://conductscience.org/library/papers/31551421 | PubMed |
| 2 | 34725428 | Persistent Plasmodium falciparum infections enhance transmission-reducing immunity development. | Sci Rep | 2021 | https://conductscience.org/library/papers/34725428 | PubMed |
| 3 | 33561016 | Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33561016 | PubMed |
| 4 | 20124702 | PHENIX: a comprehensive Python-based system for macromolecular structure solution. | Acta Crystallogr D Biol Crystallogr | 2010 | https://conductscience.org/library/papers/20124702 | PubMed |
| 5 | 2865324 | Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. | J Exp Med | 1985 | https://conductscience.org/library/papers/2865324 | PubMed |
| 6 | 19461840 | Phaser crystallographic software. | J Appl Crystallogr | 2007 | https://conductscience.org/library/papers/19461840 | PubMed |
| 7 | 23086475 | Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. | Nat Med | 2012 | https://conductscience.org/library/papers/23086475 | PubMed |
| 8 | 29162799 | Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. | Nat Commun | 2017 | https://conductscience.org/library/papers/29162799 | PubMed |
| 9 | 35963275 | Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/35963275 | PubMed |
| 10 | 32075877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 11 | 28807998 | Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28807998 | PubMed |
| 12 | 29422648 | Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity. | Nat Commun | 2018 | https://conductscience.org/library/papers/29422648 | PubMed |
| 13 | 34368623 | Improved protein structure prediction by deep learning irrespective of co-evolution information. | Nat Mach Intell | 2021 | https://conductscience.org/library/papers/34368623 | PubMed |
| 14 | 32566259 | Malaria vaccines since 2000: progress, priorities, products. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32566259 | PubMed |
| 15 | 35812379 | Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine Candidates. | Front Immunol | 2022 | https://conductscience.org/library/papers/35812379 | PubMed |
| 16 | 32079680 | Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab. | Science | 2020 | https://conductscience.org/library/papers/32079680 | PubMed |
| 17 | 33964223 | Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. | Lancet | 2021 | https://conductscience.org/library/papers/33964223 | PubMed |
| 18 | 26488565 | Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26488565 | PubMed |
| 19 | 28539451 | Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers. | J Virol | 2017 | https://conductscience.org/library/papers/28539451 | PubMed |
| 20 | 2668861 | Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. | Parasitology | 1989 | https://conductscience.org/library/papers/2668861 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42722653 | The transmission-blocking dynamics of Plasmodium falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adults. | Nat Commun | 2026 | https://conductscience.org/library/papers/42722653 | PubMed |
| 42226229 | Genetic diversity of the Plasmodium falciparum Pfs230 gene in four East African countries supports its potential as a malaria transmission‑blocking vaccine candidate. | Malar J | 2026 | https://conductscience.org/library/papers/42226229 | PubMed |
| 41727579 | The kinetics and transmission-blocking dynamics of P. falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adults. | Res Sq | 2026 | https://conductscience.org/library/papers/41727579 | PubMed |
| 41580424 | A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity. | Nat Commun | 2026 | https://conductscience.org/library/papers/41580424 | PubMed |
| 41267740 | Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples. | Wellcome Open Res | 2025 | https://conductscience.org/library/papers/41267740 | PubMed |
| 41202138 | Pfs230 domain 12 is a potent malaria transmission-blocking vaccine candidate. | Sci Adv | 2025 | https://conductscience.org/library/papers/41202138 | PubMed |
| 41172338 | Pfs230 Domains 7-10 Encoded by DNA Vaccines Induce Potent Complement-Independent Transmission-Blocking Antibody Against Plasmodium falciparum. | J Infect Dis | 2026 | https://conductscience.org/library/papers/41172338 | PubMed |
| 40033373 | Antibody correlates of risk of clinical malaria in an area of low and unstable malaria transmission in western Kenya. | Malar J | 2025 | https://conductscience.org/library/papers/40033373 | PubMed |
| 39907429 | Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions. | Immunol Rev | 2025 | https://conductscience.org/library/papers/39907429 | PubMed |
| 39817720 | Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats. | Elife | 2025 | https://conductscience.org/library/papers/39817720 | PubMed |
| 39555079 | ProC6C, a novel multi-stage malaria vaccine, elicits functional antibodies against the minor and central repeats of the Circumsporozoite Protein in human adults. | Front Immunol | 2024 | https://conductscience.org/library/papers/39555079 | PubMed |
| 39209843 | Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria. | Nat Commun | 2024 | https://conductscience.org/library/papers/39209843 | PubMed |
| 39018754 | Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum. | EBioMedicine | 2024 | https://conductscience.org/library/papers/39018754 | PubMed |
| 38988315 | Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes. | Protein Sci | 2024 | https://conductscience.org/library/papers/38988315 | PubMed |
| 38793797 | A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38793797 | PubMed |
| 38656211 | Vaccines and monoclonal antibodies: new tools for malaria control. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38656211 | PubMed |
| 38086855 | Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/38086855 | PubMed |
| 37542029 | A human antibody epitope map of the malaria vaccine antigen Pfs25. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/37542029 | PubMed |
| 37481347 | Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein. | Trends Parasitol | 2023 | https://conductscience.org/library/papers/37481347 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| DNAJC5 | 80331 | PubTator's text mining | https://conductscience.org/library/genes/80331 | NCBI Gene |
| FANCB | 2187 | PubTator's text mining | https://conductscience.org/library/genes/2187 | NCBI Gene |
| IGHV1-69 | 28461 | PubTator's text mining | https://conductscience.org/library/genes/28461 | NCBI Gene |
| IGKV1-5 | 28299 | PubTator's text mining | https://conductscience.org/library/genes/28299 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| MLC1 | 23209 | PubTator's text mining | https://conductscience.org/library/genes/23209 | NCBI Gene |
| SCFV | 652070 | PubTator's text mining | https://conductscience.org/library/genes/652070 | NCBI Gene |
| SUCO | 51430 | PubTator's text mining | https://conductscience.org/library/genes/51430 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36792575
GET https://conductscience.org/api/papers/v1/36792575/authors?page=2